BFC Planning’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-49
Closed -$1.22K – 3480
2026
Q2
$1.22K Buy
49
+4
+9% +$94 ﹤0.01% 3106
2026
Q1
$630 Hold
45
– – ﹤0.01% 2819
2025
Q4
$505 Hold
45
– – ﹤0.01% 2925
2025
Q3
$520 Buy
+45
New +$527 ﹤0.01% 2740
2025
Q2
– Sell
-45
Closed -$645 – 2676
2025
Q1
$645 Hold
45
– – ﹤0.01% 2499
2024
Q4
$716 Hold
45
– – ﹤0.01% 2451
2024
Q3
$1.08K Buy
+45
New +$1.03K ﹤0.01% 2391

Other funds holding AVNS

BFC Planning's AVNS Position: Q3 2026 in Review

BFC Planning sold out of Avanos Medical (AVNS) in Q3 2026, closing a stake of 49 shares — an estimated $1.22K sold.

BFC Planning first reported a position in AVNS in Q3 2024 and held it in 7 quarters. The position peaked at $1.22K in Q2 2026. 2 funds tracked by Wall St. Rank hold AVNS as of Q3 2026.

  • BFC Planning reported no remaining Avanos Medical position as of Q3 2026 after selling out during the quarter.
  • BFC Planning sold 49 Avanos Medical shares in Q3 2026, an estimated $1.22K.
  • BFC Planning first reported a position in Avanos Medical in Q3 2024 and held it in 7 quarters.
  • BFC Planning's Avanos Medical position peaked at $1.22K in Q2 2026.
  • 2 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.